Healthtech Startups
16,988 companies tagged Healthtech, with their investors and founders.
DoctorMate provides online medical support services to care facilities, offering 24/7 on-call backup from physicians and nurses, specialist consultations, and telemedicine for residents. The service is designed to reduce nurse workload and prevent unnecessary emergency transports at long-term care facilities.
2 investors
Trinity Technology (renamed Kokoro no Company as of April 2026) provides digital and AI-enabled services for Japan's aging society, addressing asset freezing from dementia, elder care management, inheritance procedures, business succession, and out-of-pocket care services. The company operates multiple service lines combining technology with personalized support for seniors and their families.
2 investors
Toregem Biopharma is a Kyoto University spin-off developing a tooth-regeneration drug based on a humanized anti-USAG-1 antibody that aims to regrow teeth with a single injection. It initially targets patients with congenital tooth agenesis (a rare genetic condition) and ultimately aims to treat tooth loss from decay or periodontal disease.
2 investors
NeuroSpace provides corporate sleep-improvement services for working professionals, including sleep seminars, a 7-week improvement program (Biz Sleep), sleep checks, and sleep apnea surveys. Founded in 2013, it serves companies and municipalities in Japan focused on employee health and well-being.
2 investors
BackTech develops Pocket Therapist, a digital platform connecting employees with physical therapists and health professionals to address musculoskeletal pain and wellness issues in workplace health management. The service uses technology to bridge employees and specialists across time and location for occupational health interventions.
2 investors
BrightPath Bio develops novel cancer immunotherapy medicines and cell therapy treatments that enhance the body's natural immune response to eliminate cancer cells. The company builds a platform for developing cell and antibody therapeutics across different cancer types and target antigens, with plans to expand into other immune-modulation therapeutic areas.
2 investors
MedUp develops and provides medical/healthcare IT systems, including software supporting regional healthcare collaboration for medical institutions. The company operates in Japan's healthcare technology sector.
2 investors
Medley develops digital healthcare platforms and services for the Japanese medical industry, including a job placement site for healthcare workers, telemedicine services, and medical information resources. The company aims to improve healthcare delivery, operational efficiency for medical institutions, and patient experience through technology solutions.
2 investors
AFI manufactures rapid microbial detection systems using flow cytometry and solid-phase cytometry technologies for quality control in pharmaceuticals, clinical diagnostics, cosmetics, food and beverage, and environmental testing.
2 investors
EXORPHIA develops extracellular vesicle (EV) technology for assisted reproductive medicine, focusing on cell-free IVF culture medium additives to improve embryo development and fertilization success rates. The company targets fertility clinics and academic institutions in reproductive medicine.
2 investors
iXgene develops regenerative medicine therapies using genome-edited induced pluripotent stem cells (iPSCs) to treat conditions including glioblastoma and traumatic brain injury. The company focuses on gene and cell therapies derived from genetically engineered stem cells.
2 investors
Lifescapes develops brain-machine interface (BMI) technologies, including medical-grade and rehabilitation-focused devices for hand and finger control applications.
2 investors
Luxonus develops photoacoustic (optical ultrasound) 3D imaging devices and services for visualizing blood and lymphatic vessels, building on technology from Japan's Cabinet Office ImPACT program. The company designs, manufactures, and sells medical imaging equipment based on photoacoustic technology, and is based in Japan.
2 investors
Smart119 develops ICT-based technology aimed at solving problems in medical and emergency care settings to help treat more patients. The company applies information and communications technology to deliver advanced medical care in Japan.
2 investors
Xenoma develops e-skin, a washable garment-type IoT device embedded with stretchable sensors that measures healthcare data when worn. The company uses this technology for at-home medical testing services, including a 3-lead Holter electrocardiogram mailed for home use, aiming at preventive care for cardiovascular and other diseases.
2 investors
YStory develops AI-powered digital health solutions for women, with a focus on menopause management. The company offers JoyHer, a smartphone app that provides symptom tracking, expert articles, and community support for women navigating menopause in Japan.
2 investors
Chiome is a Japanese biotech venture that discovers and develops antibody drugs targeting unmet medical needs. It works to create drug candidates and build product pipelines through collaboration with external institutions.
2 investors
Silvacompass develops software applications and provides business support services for the healthcare and senior care sectors, alongside big data collection and analysis capabilities.
2 investors
TWOCELLS (株式会社ツーセル) is a regenerative medicine venture developing therapies and products based on mesenchymal stem cells (MSCs), including its gMSC series for cartilage regeneration, along with serum-free culture media (STK series) and consulting services. Founded as a Hiroshima University spin-off, it also licenses its technology to pharmaceutical partners.
2 investors
Digireha (株式会社デジリハ) develops digital rehabilitation tools for people with disabilities, working under the mission of building a future not constrained by disability. The company frames disability through the "social model," treating the difficulties disabled people face as originating in society rather than the individual.
2 investors
MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.
2 investors
Japanese healthcare startup (Mental Health Technologies, Inc.) that runs businesses in mental health solutions, medical workforce shift services, medical career support, and digital marketing, centered on connecting companies with physicians to address employees' physical and mental health. It serves corporate employers seeking to improve workforce well-being and occupational health.
2 investors
Rehasaku provides cloud-based rehabilitation and physical therapy management systems for medical institutions and treatment clinics in Japan. The platform includes exercise therapy management, guidance support tools, AI-powered posture analysis, appointment scheduling, and web marketing support.
2 investors
Ribomic is a company with a U.S. subsidiary engaged in research and development, including pharmaceutical and research-ethics-related activities. The page describes its compliance program, ethics committee, employee training, whistleblower hotline, and management of public research funding.
2 investors